Risk Reduction Therapies for Patients with Coronary Artery Disease: A Call for Increased Implementation

This publication has 12 references indexed in Scilit:

• Angiographic progression of coronary artery disease and the development of myocardial infarction
  Published by Elsevier ,2004
• Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
  Journal of the American College of Cardiology, 1995
• Coronary Plaque Disruption
  Circulation, 1995
• Quality of Care for Medicare Patients With Acute Myocardial Infarction
  JAMA, 1995
• Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
  New England Journal of Medicine, 1995
• Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group.
  Circulation, 1994
• Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.
  Heart, 1993
• Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography
  Published by Elsevier ,1992
• Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.
  Circulation, 1991
• Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
  Circulation, 1988